104 related articles for article (PubMed ID: 8566006)
21. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
[TBL] [Abstract][Full Text] [Related]
22. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy?
Chiocchia G; Manoury-Schwartz B; Boissier MC; Gahery H; Marche PN; Fournier C
Eur J Immunol; 1994 Nov; 24(11):2775-83. PubMed ID: 7525304
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.
Kovac Z; Schwartz RH
J Immunol; 1985 May; 134(5):3233-40. PubMed ID: 2580020
[TBL] [Abstract][Full Text] [Related]
24. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift.
Mo JA; Holmdahl R
J Immunol; 1996 Sep; 157(6):2440-8. PubMed ID: 8805643
[TBL] [Abstract][Full Text] [Related]
25. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
26. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
27. Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis.
Guéry L; Chiocchia G; Batteux F; Boissier MC; Fournier C
Gene Ther; 2001 Dec; 8(24):1855-62. PubMed ID: 11821939
[TBL] [Abstract][Full Text] [Related]
28. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
[TBL] [Abstract][Full Text] [Related]
29. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
[TBL] [Abstract][Full Text] [Related]
30. Deficient antigen processing of a protein quaternary structure can be overcome by receptor-mediated uptake.
Rouas-Freiss N; Housseau F; Bidart JM; Bonnerot C; Amigorena S; Guillet JG; Bellet D
Eur J Immunol; 1993 Dec; 23(12):3335-44. PubMed ID: 7504994
[TBL] [Abstract][Full Text] [Related]
31. Time dependence of B cell processing and presentation of peptide and native protein antigens.
Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
[TBL] [Abstract][Full Text] [Related]
32. Peptides related to the antigenic determinant block T cell recognition of the native protein as processed by antigen-presenting cells.
Lakey EK; Margoliash E; Flouret G; Pierce SK
Eur J Immunol; 1986 Jul; 16(7):721-7. PubMed ID: 2424770
[TBL] [Abstract][Full Text] [Related]
33. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
34. Freshly isolated mouse 4F7+ splenic dendritic cells process and present exogenous antigens to T cells.
Mohamadzadeh M; Pavlidou A; Enk A; Knop J; Rüde E; Gradehandt G
Eur J Immunol; 1994 Dec; 24(12):3170-4. PubMed ID: 7805745
[TBL] [Abstract][Full Text] [Related]
35. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
36. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
37. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
38. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis.
Myers LK; Seyer JM; Stuart JM; Terato K; David CS; Kang AH
J Immunol; 1993 Jul; 151(1):500-5. PubMed ID: 7686947
[TBL] [Abstract][Full Text] [Related]
39. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
40. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
